Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - Ampio Pharmaceuticals, Inc. | tv487181_ex32-1.htm |
| EX-31.2 - EXHIBIT 31.2 - Ampio Pharmaceuticals, Inc. | tv487181_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - Ampio Pharmaceuticals, Inc. | tv487181_ex31-1.htm |
| 10-K - FORM 10-K - Ampio Pharmaceuticals, Inc. | tv487181_10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in Ampio Pharmaceuticals, Inc.’s Registration Statements on Form S-8 (File Nos. 333-186077, 333-181626, 333-175161, and 333-194428) and Form S-3 (File No. 333-217094) of our report dated March 6, 2018, relating to the financial statements, which includes an explanatory paragraph regarding the substantial doubt about Ampio Pharmaceuticals, Inc.’s ability to continue as a going concern, which appears in this Annual Report on Form 10-K.
/s/ EKS&H LLLP
March 6, 2018
Denver, Colorado